We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BNN market cap is 62.27M. The company's latest EPS is EUR -0.3789 and P/E is -24.89.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 41.02M | 39.35M | 40.26M | 50.48M | 55.74M |
| Operating Income | -8.95M | -10.56M | -8.24M | -8.19M | -6.37M |
| Net Income | -10.48M | -9.68M | -4.97M | -6.59M | -8.28M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 66.12M | 72.15M | 77.74M | 77.99M | 70.94M |
| Total Liabilities | 49.03M | 46.01M | 35.91M | 43.74M | 47.92M |
| Total Equity | 17.09M | 26.14M | 41.83M | 34.25M | 23.01M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -3.38M | -4.77M | -3.91M | -1.49M | -4.22M |
| Investing | -6.74M | -4.47M | -2.18M | -12.69M | 562k |
| Financing | -277k | 13.09M | 11.57M | -1.97M | 459k |
| Market Cap | 62.27M |
| Price to Earnings Ratio | -24.89 |
| Price to Sales Ratio | 3.7 |
| Price to Cash Ratio | 38.49 |
| Price to Book Ratio | 8.95 |
| Dividend Yield | - |
| Shares Outstanding | 21.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.12 (4.12%) |
| Company Name | BRAIN Biotech AG |
| Address |
darmstaedter strasse 34-36 zwingenberg 64673 |
| Website | https://www.brain-biotech.de |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
